Smoking as a modifier of the systolic blood pressure-induced risk of cardiovascular events and mortality: a population-based prospective study of middle-aged men
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 20 (9) , 1759-1764
- https://doi.org/10.1097/00004872-200209000-00019
Abstract
To examine to what degree smoking habits modulate the relationship between systolic blood pressure (SBP) and risk for cardiovascular morbidity (first event) and mortality in middle-aged men. In all, 22 444 middle-aged men were recruited from a population-based screening study (mean attendance rate 71%). Risk factor intervention was offered to about 20% of participants. Subjects were followed in local and national registers for cardiovascular morbidity and mortality during more than 17 years of follow-up. Life-style variables were investigated at baseline, including smoking habits. Event rates were calculated in relation to quintiles (Q1-Q5) of baseline SBP in untreated subjects, subdivided into categories of smoking habits, but also for 915 previously known, treated hypertensive (tHT) patients at baseline. We found an increasing incidence of first cardiovascular event (CE) with increasing SBP levels, ranging from 63.5 CE/10 000 person-years (Q1) to 62.3, 70.5, 82.3 and 115.1 CE/10 000 person-years (Q2-Q5). The corresponding figure in tHTs was 153 CE/10 000 person-years. If further subdivided into smokers/ex-smokers/non-smokers, the relative risks (RR) of smokers were 1.9 [95% confidence interval (CI): 1.5-2.4], 2.1 (1.8-2.5), 2.3 (1.8-2.9), 1.8 (1.5-2.1), and 1.7 (1.5-2.0) compared to present non-smokers, in relation to SBP (Q1-Q5). In tHTs the RR was 1.4 (1.1-1.8). Cardiovascular mortality rates differed in relation to SBP and smoking habits, from 40.3 (present non-smokers) and 70.7 (smokers) deaths/10 000 person-years in Q1, to 54.2 and 134.0 deaths/10 000 person-years in Q5. In tHTs the corresponding figures were 81.6 and 149.4 deaths/10 000 person-years, respectively. No difference in risk was found for never-smokers compared to ex-smokers in relation to SBP. The risk in moderate/heavy smokers ( 10 cigarettes/day) compared to other smokers (<or= 10 cigarettes/day) was significantly ( 0.005) increased only in Q5. Increasing systolic blood pressure levels in middle-aged men is associated with an increasing risk of future cardiovascular events and mortality, an association modified by smoking habits. Patients with treated hypertension in the 1970-1980s were also at an increased risk in spite of healthcare efforts. This calls for a more comprehensive multiple risk factor approach for the management and reduction of cardiovascular risk in these patients.Keywords
This publication has 19 references indexed in Scilit:
- Evidence based management of hypertension: Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based reviewBMJ, 2001
- Long‐term outcome of the Malmö Preventive Project: mortality and cardiovascular morbidityJournal of Internal Medicine, 2000
- Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive ProjectJournal of Internal Medicine, 1996
- Cardiovascular risk factors in treated hypertensives—a nation‐wide, cross‐sectional study in SwedenJournal of Internal Medicine, 1993
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Goteborg, SwedenPublished by American Medical Association (AMA) ,1987
- Mortality and Morbidity in Relation to Systolic Blood Pressure in Two Populations with Different Management of Hypertension: The Study of Men Born in 1913 and the Multifactorial Primary Prevention TrialJournal Of Hypertension, 1987
- Predictors of Cardiovascular Morbidity in Treated Hypertension: Results from the Primary Preventive Trial in Goteborg, SwedenJournal Of Hypertension, 1985
- High Risk of Cerebro‐cardiovascular Morbidity in Well Treated Male HypertensivesActa Medica Scandinavica, 1984
- Morbidity and Mortality in Relation to Blood Pressure and Antihypertensive TreatmentActa Medica Scandinavica, 1984